| Financial Year |
March 31 2023 |
| Monetary Funds |
6,144,343,432.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,708,747,764.48 |
| Advances to Suppliers |
1,083,360,606.64 |
| Other Receivables |
383,127,062.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
24,212,460.00 |
| Inventories |
1,519,720,965.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
468,603,570.38 |
| Total Current Assets |
13,455,156,738.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
711,953,235.48 |
| Investment Properties |
25,170,634.06 |
| Fixed Assetes |
21,337,864,449.84 |
| Under-construction Projects |
6,817,400,864.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,431,722,593.58 |
| R&D expenses |
-- |
| Goodwill |
185,828,911.21 |
| Long-Term Deferred and Prepaid Expenses |
530,228,863.13 |
| Deferred Income Tax Assets |
245,817,351.26 |
| Other Non-Current Assets |
1,630,086,344.00 |
| Sub-Total of Non-Current Assets |
35,486,454,889.94 |
| Total Assets |
48,941,611,628.59 |
| Short-Term Loans |
1,030,910,461.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,733,311,803.66 |
| Accounts Received In Advance |
220,312.10 |
| Employee Compensation Payable |
428,196,694.92 |
| Taxes Payable |
583,285,007.01 |
| Interest Payable |
-- |
| Dividend Payable |
5,849.30 |
| Other payables |
958,802,010.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
414,241,524.58 |
| Other Current Liabilities |
81,414,614.52 |
| Sub-Total of Current Liabilities |
6,693,425,087.97 |
| Long-term Loans |
8,059,666,080.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
562,707,044.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
13,286,121.13 |
| Deferred Income Tax Liabilities |
18,313,423.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,058,394,210.66 |
| Total Liabilities |
15,751,819,298.63 |
| Paid-In Capital(Or Share Stock) |
2,241,573,493.00 |
| Capital Surplus |
6,348,411,215.89 |
| Surplus Reserve |
1,078,061,162.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
19,339,681,561.65 |
| Minority Stockholder's Interest |
3,951,960,706.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,237,831,623.46 |
| Owner's Equity（Stockholder's Equity） |
33,189,792,329.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,941,611,628.59 |
